The following information is about Antigen.

Antigen? A Basic Definition

No Matching Dairy Production News

No news for Antigen is available at this time.

Are you looking for additional Dairy Production > Antigen news? Try our new "Antigen News Focus" area.

Off-site Antigen Links, User Submitted

The following links have been collected through user bookmark submission in the Antigen category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Wed Jun 17

• B Cells and T Cells

Thu May 21

• Hepatitis Testing: Hepatitis B is a serious disease caused by a virus that attacks the liver. The virus, which is called hepatitis B virus (HBV), can cause lifelong infection, cirrhosis (scarring) of the liver, liver cancer, liver failure, and death. Approximately 200,000 new HBV infections in the United States each year, approximately half are transmitted through sexual intercourse.

Thu Apr 30

• MIF Bioinformatics : Tools >> PREDICTED ANTIGENIC PEPTIDES
• Antigenicity Plot
• EMBOSS: output

Thu Apr 9

• BIACore Information

Tue Apr 7

• Blood Groups: Good government site for higher level yr8 students to visit. Explains antigens and what they do in blood as well as the basic stuff.

Thu Apr 2

• Chapter 2 - Installation

Tue Mar 31

• YouTube - Immune System, White Blood Cells, T-Cells, Cancer Cells

Tue Mar 24

• Installing Microsoft Antigen for Exchange

Mon Mar 23

• Microsoft Antigen E-mail Server Security Products: Features

Thu Mar 19

• NEJM -- Mortality Results from a Randomized Prostate-Cance r Screening Trial: The effect of screening with PSA testing and digital rectal examination on the rate of death from prostate cancer is unknown. From 1993 through 2001, we randomly assigned 76,693 men to receive either annual screening or usual care as the control. After 7 to 10 years of follow-up, the rate of death from prostate cancer was very low and did not differ significantly between the two study groups.

Mon Mar 16

• Oxford BioMedica - TroVax®: TroVax is a novel therapeutic cancer vaccine that has potential application in most solid tumour types. The vaccine is designed to induce an immune response against the tumour-associa ted antigen 5T4 using a viral vector, Modified Vaccinia Ankara (MVA). The 5T4 tumour antigen is a unique target, which is expressed at high levels in the majority of epithelial-der ived cancers such as colorectal, renal, prostate, lung and breast.

Mon Mar 2

• VaxiJen

Thu Feb 26

• Forefront Server Security Support Blog : Welcome to the FSS Support Blog

Off-site Antigen Research Links

If you still need additional information on Antigen then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.